Panel Inhalation allergens (16)

The Inhalant Allergen Panel (16) is a serological allergy screening test used for the initial assessment of IgE-mediated sensitization to the most common inhalant allergens found in the environment, including house dust mites, animal epithelia, molds, and pollens from trees, grasses, and weeds.

The test detects the presence of allergen-specific IgE antibodies against a mixture of inhalant allergens and serves as the first step in the evaluation of patients with symptoms suggestive of respiratory allergies. The results help guide further allergy investigations and support the selection of subsequent diagnostic steps based on the patient's clinical manifestations and medical history.

Indications

• recurrent sneezing, nasal congestion, or runny nose without signs of infection;
• itchy eyes, excessive tearing, or symptoms suggestive of allergic conjunctivitis;
• persistent cough, wheezing, or symptoms suggestive of allergic asthma;
• respiratory symptoms occurring seasonally or in specific environments (at home, at work, or after contact with animals);
• suspected allergic rhinitis, allergic conjunctivitis, or allergic bronchial asthma;
• initial evaluation of patients with suspected sensitization to inhalant allergens.

Profile composition

Procedure

The analysis is performed using a venous blood sample collected from the antecubital vein. The procedure takes only a few minutes and is carried out by qualified healthcare professionals.

Method of Analysis

Determination of serum allergen-specific IgE antibodies against a mixture of inhalant allergens using an automated immunological assay.

Interpretation of Results

The test provides an initial assessment of sensitization to the main categories of inhalant allergens included in the panel. If the result is positive, the allergist may recommend additional testing for specific individual allergens, selected according to the patient's symptoms and medical history, to obtain a more detailed characterization of the allergic profile.